No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Drugs
Drusolv targets macular degeneration with statin therapy
Drugs
It’s time to sit up and take notice of mitochondria
Drugs
Life Biosciences in-licenses IP from new studies
New studies in Nature "open a new frontier in biotechnology and medicine," says Life Biosciences CEO Mehmood Khan.
Drugs
New Buck Institute study is treasure trove for longevity research
Drugs
Longevity Escape Velocity within 10 years?
Drugs
“Adjust the immune system… de-age the brain”
Drugs
AI to quantify senescent cell counts
Drugs
Senolytic start-up gears up for clinical trials
Drugs
Gerostate Alpha: “Our phenotype is lifespan”
Drugs
CohBar announces preclinical collaboration with NIAID
Drugs
“The major modulators of aging remain to be discovered”
Drugs
New Longevity supplement targets cognitive decline
Drugs
Senescence and the return of established splicing tech
Drugs
Longevity companies to watch in 2021
Drugs
Juvenescence (1): from strength to strength in R&D and investment firepower
Drugs
A year in Longevity: progress perspectives
Drugs
A year in Longevity: different perspectives
Drugs
A year in Longevity: founders’ perspectives
Drugs
A year in Longevity: science perspectives
Drugs
VC and drug developer scale-up their incubator model
Drugs
Eliminating senescent cells to improve heart attack recovery
Drugs
Sigilon IPO raises $145m to address chronic diseases
Drugs
Deep Longevity reveals highly-accurate aging clock
Drugs
Calico’s memory-enhancing drug reverses age-related mental decline
Drugs
BioAge CEO: “It’s all about the data.”
Drugs
Silicon Valley is waking up to Longevity and senolytics
Drugs
BioAge lands $90 million; gears up for clinical trials in 2021
Drugs
Targeting inflammaging: the hidden “inflammapath” inside us
Drugs
Found: the missing link in the Longevity ‘supply-chain’
Drugs
AgelessRx and funding an IRB-approved rapamycin trial
Drugs
Will rapamycin overtake metformin as a Longevity therapy?
Drugs
Biogen Alzheimer’s drug closer to FDA approval
Drugs
Load More